Ohio study links GLP-1 drugs to restaurant issues

A recent study indicates that the increasing use of GLP-1 weight-loss drugs, such as Ozempic and Wegovy, is leading Americans to dine out less and modify their eating habits. Two-thirds of users reported reduced spending at restaurants, with many cutting back on desserts, sugary drinks, and alcoholic beverages. As a result, the restaurant industry may need to adapt by offering smaller portions and high-protein options to meet changing consumer preferences.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل